Humira Buyers Ask 7th Circ. To Revive 'Patent Thicket' Case
By Matthew Perlman · October 6, 2020, 8:16 PM EDT
Humira buyers have urged the Seventh Circuit to revive their suit claiming AbbVie built an anti-competitive "patent thicket" around its blockbuster immunosuppressant drug Humira to keep cheaper biosimilars from coming to...
To view the full article, register now.